Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Atlas of Genetics and Cytogenetics in Oncology and Haematology OPEN ACCESS JOURNAL AT INIST-CNRS Leukaemia Section Short Communication t(12;21)(p12;q22) Jean-Loup Huret, Alain Bernheim Genetics, Dept Medical Information, University of Poitiers, CHU Poitiers Hospital, F-86021 Poitiers, France (JLH); Laboratoire de Cytogénétique, UMR 1599 CNRS, Institut Gustave Roussy, 94805 Villejuif, France (AB) Published in Atlas Database: August 1997 Online version is available at: http://AtlasGeneticsOncology.org/Anomalies/t1221.html DOI: 10.4267/2042/32031 This work is licensed under a Creative Commons Attribution-Non-commercial-No Derivative Works 2.0 France Licence. © 1997 Atlas of Genetics and Cytogenetics in Oncology and Haematology Clinics and pathology Genes involved and Proteins Disease ETV6 B cell ALL Phenotype / cell stem origin L1 and L2, CD10+. Epidemiology 15 to 35% of paediatric B-lineage ALL: so far the most frequent translocation in this group; rare or absent in adults and in infants; age: children; no case > 20 yrs so far; male and female equally represented. Clinics Standard ALL. Prognosis CR in all cases; prognosis seems good. Location: 12p13 DNA / RNA 9 exons; alternate splicing. Protein Contains a HLH domain and a ETS-DNA binding domain; wide expression; nuclear localisation; ETSrelated transcription factor. AML1 Location: 21q22 DNA / RNA Transcription is from telomere to centromere. Protein Contains a Runt domain and, in the C-term, a transactivation domain; forms heterodimers; widely expressed; nuclear localisation; transcription factor (activator) for various hematopoietic-specific genes. Cytogenetics Cytogenetics, morphological t(12;21) often remained undetected. Easily detected by chromosomes 12 and 21 painting or specific probes. Results of the chromosomal anomaly Additional anomalies Hybrid gene Frequent del(12)(p12) on the other chromosome; in rare cases duplication of der(21)t(12;21); looks like a +21. Description TEL-AML1 chimaeric gene; 5' centromere to 3' telomere orientation. Transcript The fusion transcript on chromosome 21 TEL-AML1 is the crucial one; the AML1-TEL transcript is absent in some cases; the other TEL allele is often deleted. Cytogenetics, molecular Variants t(6;12;21), t(3;12;21) Atlas Genet Cytogenet Oncol Haematol. 1997; 1(1) 19 t(12;21)(p12;q22) Huret JL, Bernheim A Romana SP, Poirel H, Leconiat M, Flexor MA, Mauchauffé M, Jonveaux P, Macintyre EA, Berger R, Bernard OA. High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. Blood 1995 Dec 1; 86(11):4263-9. Raynaud S, Cave H, Baens M, Bastard C, Cacheux V, Grosgeorge J, Guidal-Giroux C, Guo C, Vilmer E, Marynen P, Grandchamp B. The 12; 21 translocation involving TEL and deletion of the other TEL allele: two frequently associated alterations found in childhood acute lymphoblastic leukemia. Blood 1996 Apr 1; 87(7):2891-9. Detection protocol RT-PCR of the fusion transcript. Fusion protein Description Helix loop helix of TEL fused to the nearly entire AML1 protein, comprising the Runt domain and the transactivation domain. References This article should be referenced as such: Huret JL, Bernheim A. t(12;21)(p12;q22). Cytogenet Oncol Haematol.1997;1(1):19-20. Golub TR, Barker GF, Lovett M, Gilliland DG. Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 1994 Apr 22; 77(2):307-16. Atlas Genet Cytogenet Oncol Haematol. 1997; 1(1) 20 Atlas Genet